Infectious causes of atherosclerosis

American Heart Journal

Volumn 137, Issue 2, 1999, Pages 216-226

  Kuvin, Jeffrey T ^a   Kimmelstiel, Carey D ^a,b  

^a TUFTS MEDICAL CENTER   (United States)

^b Division of Cardiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; ROXITHROMYCIN;

ATHEROGENESIS; ATHEROSCLEROSIS; CHLAMYDIA; CHLAMYDIASIS; CORONARY ARTERY DISEASE; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; HEART TRANSPLANTATION; HELICOBACTER PYLORI; HISTORY OF MEDICINE; HUMAN; INFECTION; INFLAMMATION; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESTENOSIS; REVIEW; VIRUS INFECTION;

EID: 0032911650     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1053/hj.1999.v137.92261     Document Type: Article

References (56)

1. 1. Frothingham C. The relationship between acute infectious diseases and arterial lesions. Arch Int Med 1911;8:153-62.
2. 2. Nieminen M, Voltonen V. Infection and inflammation as risk factors for myocardial infarction. Eur Heart J 1993; 14:12-6.
3. 3. Stanier R, Doudoroff M, Adelberg E. The beginnings of microbiology. In: Stanier R, Doudoroff M, Adelberg E. The microbial world. 2nd ed. Englewood Cliffs, (NJ): Prentice-Hall; 1963. p. 3-28.
4. 4. Klotz O, Manning M. Fatty streaks in the intima of arteries. J Pathol Bacteriol 1912;16:211-20.
5. 5. Osler W. Diseases of the arteries. In: Osler W, editor. Modern medicine: its practice and theory. Philadelphia: Lea and Febiger; 1908. p. 429-47.
6. 6. Paterson JC, Cattral GE. Experimental coronary sclerosis: lymphomatosis as a cause of coronary sclerosis in chickens. Arch Pathol 1950;49:699-709.
7. 7. Fabricant CG, Fabricant J, Litrenra M, Minick C. Virus-induced atherosclerosis. J Exp Med 1978;148:335-40.
8. 8. Minick CR, Fabricant CG, Fabricant J, Litrent M. Atherosclerosis induced by infection with a herpesvirus. Am J Pathol 1979; 96:673.
9. 9. Fabricant CG, Hajjar DP, Minick CR, Fabricant J. Herpes infection enhances cholesterol and cholesteryl ester accumulation in cultured arterial smooth muscle cells. Am J Pathol 1981;105:176-84.
10. 10. Hajjar DP, Fabricant CG, Minick CR, Fabricant J. Virus induced atherosclerosis: herpesvirus infection alters aortic cholesterol metabolism and accumulation. Am J Pathol 1986;122:62-70.
11. 11. Virchow R. Phlogose and thrombose in gefassystem, gesammelte abhandlungen zur wissenschaftlichen medicin. Frankfurt-am-Main: Meidinger Sohn; 1856. p. 458.
12. 12. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-9.
13. 13. Serneri G, Prisco D, Martini F. Acute T-cell activation is detectable in unstable angina. Circulation 1997;95:1806-12.
14. 14. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-50.
15. 15. Ridker P, Cushman M, Stampfer M, Tracy R, Hennekens C. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
16. 16. Melnick J, Adam E, DeBakey M. Possible role of cytomegalovirus in arherogenesis. JAMA 1990;263:2204-7
17. 17. Melnick J, Dressman G, McCollum C, Petrie B, Burek J, DeBakey M. Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet 1983;2:644-7.
18. 18. Yamashiroya H, Ghosh L, Yang R, Robertson A. Herpesviridae in the coronary arteries and aorta of young trauma victims. Am J Pathol 1988;130:71-9.
19. 19. Adam E, Melnick J, Probtsfield J, Petrie B, Burek J, Bailey K, et al. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 1987;2:291-3.
20. 20. Hendrix M, Dormans P, Kitslaar P, Bosman F, Bruggeman C. The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and nonatherosclerotic patients. Am J Pathol 1989; 134:1151-7
21. 21. Hendrix M, Salimans M, van Boven C, Bruggeman C. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol 1990;136:23-8.
22. 22. Hendrix M, Daemen M, Bruggeman C. Cytomegalovirus nucleic acid distribution within the human vascular tree. Am J Pathol 1991; 138:563-7.
23. 23. Sorlie P, Adam E, Melnick S, Folsom A, Skelton T, Chambless L, et al. Cytomegalovirus/herpesvirus and carotid atherosclerosis: the ARIC study. J Med Virol 1994;42:33-7.
24. 24. Olivari M, Kubo S, Braunlin E, Bolman R, Ring W. Five-year experience with triple-drug immunosuppressive therapy in cardiac transplantation. Circulation 1990;82:276-80.
25. 25. Gao S, Schroeder J, Hunt S, Stinson E. Retransplantation for severe accelerated coronary disease in heart transplant recipients. Am J Cardiol 1988;62:876-81.
26. 26. Grattan M, Moreno-Cabral C, Starnes V, Oyer P, Stinson E, Shumway N. Cytomegolovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989;261:3561-6.
27. 27. Grattan M. Accelerated graft atherosclerosis following cardiac transplantation: clinical perspectives. Clin Cardiol 1991;14:16-20.
28. 28. McDonald K, Rector T, Braunlin E, Kubo S, Olivari T. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Cardiol 1989;64:359-62.
29. 29. Hruban R, Wu T, Beschorner W, Cameron D, Ambinder R, Baumgartner W, et al. Cytomegalovirus nucleic acids in allografted hearts. Hum Pathol 1990;21:981-3.
30. 30. Merigan T, Renlund D, Keay S, Bristow M, Stames V, O'Connell J, et al. A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. N Engl J Med 1992;326:1182-6.
31. 31. Lemström K, Sihvola R, Bruggeman C, Häyry P, Koskinen P. Cytomegalovirus infection-enhanced cardiac allograft vasculopathy is abolished by DHPG prophylaxis in the rat. Circulation 1997; 95:2614-6.
32. 32. Speir E, Modali R, Huang E-S, Leon M, Shawl F, Finkel T, et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994;265:391-4.
33. 33. Zhou Y, Leon M, Waclawiw M, Pompa J, Yu ZX, Finkel T, et al. Association between prior Cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 1996; 335:624-30.
34. 34. Dymock IW, Lawson JM, Maclennan WJ, Ross CA. Myocarditis associated with psittacosis. Br J Clin Pract 1971;25:240-2.
35. 35. Van der Bel-Kahn JM, Watanakunakorn C, Menefee MG, Long HD, Dieter R. Chlamydia frachomatis endocarditis. Am Heart J 1978; 95:627-36.
36. 36. Juvonen J, Laurila A, Juvonen T. Detection of chlamydia pneumoniae in human nonrheumatic stenotic aortic valves. J Am Coll Cordiol 1997;29:1054-9.
37. 37. Grayston JT, Campbell LA, Kuo CC, Mordhorst CH, Saikku P, Thom DH, et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 1990;161:618-25.
38. 38. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2:983-6.
39. 39. Saikku P, Leinonen M, Tenkanen L, Linnanmaki E, Manninen V, Eckman M, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Ann Intern Med 1992;116:273-8.
40. 40. Kuo C, Grayston J, Campbell L, Goo Y, Wissler R, Benditt E. Chlamydia pneumomiae (TWAR) in coronary arteries of young adults (15 to 43 years old). Proc Natl Acad Sci 1995;92:6911-4.
41. 41. Thom D, San-Pin W, Grayston T, Siscovick D, Stewart D, Kronmal R, et al. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb 1991;11:547-51.
42. 42. Thom D, Grayston J, Siscovick D, San-Pin W, Weiss N, Doling J. Association of prior infection with chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 1992;268:68-72.
43. 43. Melnick S, Shahar E, Folsom A, Grayston J, Sorlie P, Wang S, et al. Past infection by chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Am J Med 1993;95:499-504.
44. 44. Grayston J, Kuo C, Coulson A, Campbell LA, Lawrence R, Lee MJ, et al. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 1995;92:3397-400.
45. 45. Campbell L, O'Brien E, Cappuccio A, Kuo C, Wang S, Stewart D, et al. Detection of chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis 1995;172:585-8.
46. 46. Muhlestein J, Hammond E, Carlquist J, Radicke E, Thomson M, Karagounis L, et al. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol 1996;27:1555-61.
47. 47 Ramirez J, and the Chlamydia pneumoniae Atherosclerosis Study Group. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann intern Med 1996;125:979-82.
48. 48. Gaydos C, Summersgill J, Shaney N, Ramirez J, Quinn T. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun 1996;64:1614-20.
49. 49. Fryer R, Woods M, Rodgers G. Chlamydia species infect human vascular endothelial cells and induce procoagulant activity [abstract]. Clin Res 1994;42:83A.
50. 50. Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B, for the ROXIS Study Group. Randomized trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet 1997;350:404-7.
51. 51. Gupta S, Leatham E, Carrington D, Mendall M, Kaski JC, Camm AJ. Elevated chlamydia pneumoniae antibodies, cardiovascular events and azithromycin in male survivors of myocardial infarction. Circulation 1997;96:404-7.
52. 52. Moazed T, Kuo C, Patton D, Grayston J, Campbell L. Experimental rabbit models of chlamydia pneumoniae infection. Am J Pathol 1996;148:667-76.
53. 53. Laitinen K, Laurila A, Pyhala L, Leinonen M, Saikku P. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits. Infect Immun 1997;65:4832-5.
54. 54. Muhlestein J, Anderson J, Hammond E, Shao L, Trehan S, Schwobe E, et al. Infection with C. pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 1998;97:633-6.
55. 55. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997;350:430-6.
56. 56. Visser MR, Vercellotti GM. Herpes simplex virus and atherosclerosis. Eur Heart J 1993;14:39-42.